Pages that link to "Q43248346"
Jump to navigation
Jump to search
The following pages link to Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy (Q43248346):
Displaying 50 items.
- Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials (Q26767164) (← links)
- Clinical Implications of Glucose Variability: Chronic Complications of Diabetes (Q26801671) (← links)
- Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions (Q33880525) (← links)
- Free radicals and antioxidants: updating a personal view (Q34031638) (← links)
- Acute hyperglycemia does not impair microvascular reactivity and endothelial function during hyperinsulinemic isoglycemic and hyperglycemic clamp in type 1 diabetic patients (Q34134045) (← links)
- Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? (Q34486820) (← links)
- No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. (Q34607465) (← links)
- Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics (Q34620581) (← links)
- Impact of Glycemic and Blood Pressure Variability on Surrogate Measures of Cardiovascular Outcomes in Type 2 Diabetic Patients (Q35060211) (← links)
- Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therap (Q35178857) (← links)
- Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature (Q35682645) (← links)
- Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes (Q36320582) (← links)
- The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients (Q36731094) (← links)
- Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes (Q37022682) (← links)
- Glucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic Patients (Q37054676) (← links)
- The impact of the HbA1c level of type 2 diabetics on the structure of haemoglobin (Q37254367) (← links)
- Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study (Q37289297) (← links)
- Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance (Q37292095) (← links)
- Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies. (Q37402790) (← links)
- Redox-regulating role of insulin: The essence of insulin effect (Q37924028) (← links)
- The glycemic triumvirate and diabetic complications: Is the whole greater than the sum of its component parts? (Q37953144) (← links)
- Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. (Q38016729) (← links)
- Biological variation of cardiovascular risk factors in patients with diabetes. (Q38081905) (← links)
- Glycemic variability and acute ischemic stroke: the missing link? (Q38236166) (← links)
- Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison (Q38481319) (← links)
- Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy (Q38709204) (← links)
- A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus. (Q38802810) (← links)
- Acute effects of post-absorptive and postprandial moderate exercise on markers of inflammation in hyperglycemic individuals (Q38931882) (← links)
- Glucose variability: where it is important and how to measure it. (Q40123937) (← links)
- Glucose variability (Q40124207) (← links)
- Urinary 8-iso-prostaglandin F2α as a marker of metabolic risks in the general Japanese population: The ROAD study (Q40858047) (← links)
- Glycemic variability: both sides of the story (Q41946046) (← links)
- Glycemic variability: can we bridge the divide between controversies? (Q42703555) (← links)
- A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study (Q42703568) (← links)
- 3rd Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 7–8, 2010, London, UK (Q42865106) (← links)
- Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect (Q42908291) (← links)
- Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes (Q43036250) (← links)
- Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment? (Q43201615) (← links)
- Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus (Q46133537) (← links)
- Declining ß-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: A retrospective analysis in patients with type 2 diabetes (Q46875772) (← links)
- Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus (Q47827817) (← links)
- Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring (Q48398157) (← links)
- Management of Hyperglycemia in Acute Ischemic Stroke (Q48938432) (← links)
- Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications (Q50891399) (← links)
- Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus (Q51371829) (← links)
- Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α. (Q55279804) (← links)
- Response to the Need for Identifying Standardized Indices for Measuring Glucose Variability. (Q55634217) (← links)
- Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass (Q64264027) (← links)
- Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study (Q83394019) (← links)
- Short‐term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47phox subunit in monocytes from type 2 diabetes patients (Q84557645) (← links)